-
effectivehealthcare.ahrq.gov/products/type-2-diabetes-insulin
September 15, 2008 - Comparative Effectiveness, Safety and Indications of Pre-mixed Insulin Analogues for Adults with Type 2 Diabetes
Timeline
January 01, 2005
Topic Initiated
September 15, 2008
Systematic Review
Archived
Comparative Effectiveness, Safety and Indications of Pre-m…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - Utilization of anticancer biologic products among
Medicare beneficiaries, by diagnostic cancer subchapter,
2006-2009
Anticancer Biologics Data Points #7
Fewer than 50 percent of
beneficiaries with bevacizumab
orders had a cancer diagnosis
in the prior 6 months. This was
driven by the biologic’s off-label
use …
-
effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
January 01, 2013 - Slide 1
Comparator Selection in Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparator Selection in Observational Comparative Effectiveness Research
This slide set is based on a user guide titled Developing a Protocol for Observation…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Layout 1
Background
This report evaluates the level of evidence
currently available to support the
effectiveness and safety of using
recombinant activated coagulation factor
VII (rFVIIa) for clinical indications not
approved by the U. S. Food and Drug
Administration (FDA). rFVIIa is approved
for a variety of uses i…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
November 03, 2014 - Topic 0613 Tympanostomy Tubes NSD FINAL
Tympanostomy Tubes in Children
Nomination Summary Document
Results of Topic Selection Process & Next Steps
§ Th…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
January 01, 2009 - Appendix E-1
Appendix E-1. Data Abstraction of Study Characteristics
Table E-1-1
Table E-1-1. Study characteristics of RCTs addressing Key Questions 1 and 2
Key Question Author, Year
Country
Quality Rating Demographics and Baseline Characteristics Other Population Characteristics Reason fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
May 01, 2021 - CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update
Comparative Effectiveness Review
Number 244
Safety of Vaccines Used for Routine
Immunization in the United States: An Update
Evidence Summary
Main Points
Background and Purpose
Considere…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
February 01, 2012 - 1
Comparative Effectiveness Review
Number 48
Hematopoietic Stem-Cell Transplantation in the
Pediatric Population
Executive Summary
Background
Hematopoietic stem-cell transplantation
(HSCT) refers to a procedure in which
hematopoietic progenitor cells, including
repopulating stem cells, are infused
to restore …
-
effectivehealthcare.ahrq.gov/products/search-strategies/research
June 07, 2012 - Peer Review of Search Strategies
Research Report June 7, 2012 Web Version [NLM Site] Download Main Document PDF 357.5 KB
People using assistive technology may not be able to fully access information in this file. For additional assistance, please contact us .
Structured Abstract
Background
Many s…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: June 1, 2010
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-234-headaches-pregnancy-summary.pdf
November 01, 2020 - Comparative Effectiveness Review No. 234 Evidence Summary: Management of Primary Headaches in Pregnancy
Comparative Effectiveness Review
Number 234
Management of Primary Headaches
in Pregnancy
Evidence Summary
Main Points
• Prevention of primary headache in women who are pregnant (or attempting to
become pre…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
November 01, 2020 - Comparative Effectiveness Review No. 234 Evidence Summary: Management of Primary Headaches in Pregnancy
Comparative Effectiveness Review
Number 234
Management of Primary Headaches
in Pregnancy
Evidence Summary
Main Points
• Prevention of primary headache in women who are pregnant (or attempting to
become pre…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/metanalysis-proportion-rate-comparison_research.pdf
November 01, 2013 - Simulation-Based Comparison of Methods and Meta-Analysis of Proportions and Rates
Methods Research Report
Simulation-Based Comparison of Methods for Meta-
Analysis of Proportions and Rates
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaith…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
March 01, 2015 - Such information would include
cost indicators of price or resource utilization, quality indicators … of outcomes and processes, as
well as other relevant indicators (e.g., conflicts of interest) associated … They included a
Web site if there were any indicators of a cost assigned to a health care provision … (e.g.,
use of antibiotics or length of stay) could also be quality indicators. … Weaknesses included a lack of information on out-of-pocket
expenses and an absence of indicators of
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-asthmatic-and-asthma-prone-children-what-is-the-comparative-effectiveness-of-treating-with-allergen-specific-immunotherapy-plus-standard-vs-standard-alone
September 03, 2009 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description
Topic Suggestion Description
Date submitted: September 3, 2009
Download Topic Suggestion Disposition [PDF · 100 KB]
Briefly describe a specific question, or set of related questions, about a health…
-
effectivehealthcare.ahrq.gov/products/colon-cancer-gene-profiling/research-protocol
March 13, 2012 - result from both preanalytic factors [e.g., sample preparation] as well as analytic factors [such as reagents
-
effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
April 01, 2016 - Prior research has
outlined indicators and metrics of “integration”
important in TWH interventions … HP; adequate
resources; accountability; and training.12 However,
no research has evaluated these indicators … To understand whether
integration improves both OSH and HP, researchers
need to examine indicators … Integration of health
protection and health promotion: rationale, indicators, and metrics. … Intervening to improve
health indicators among Australian farm families.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - 1
Comparative Effectiveness Review
Number 74
Progestogens for Prevention
of Preterm Birth
Executive Summary
Introduction
Burden of Preterm Birth
Birth before completion of 37 weeks of
pregnancy is considered preterm. These
early births are associated with more
than 85 percent of all perinatal morbidity
an…